brivanib and its Impurities

"Brivanib has been investigated for the treatment of Solid Tumors, Hepato Cellular Carcinoma (HCC), and Metastatic Colorectal Cancer (MCRC). It is under investigation for the treatment of HepatoCellular Carcinoma. . Reference standards of Brivanib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below

Displaying 4 results for brivanib Impurities
PA 02 45000

Brivanib

Brivanib

  • Catalogue No.:PA 02 45000

  • CAS :

    649735-46-6

  • Molecular Formula : C19H19FN4O3

  • Molecular Weight : 370.38

Enquire
Details
PA 02 45510

Brivanib Alaninate

Brivanib Alaninate

  • Catalogue No.:PA 02 45510

  • CAS :

    649735-63-7

  • Molecular Formula : C22H24FN5O4

  • Molecular Weight : 441.46

Enquire
Details
PA STI 088922

1-((4-((4-Fluoro-2-methyl-1H-indol-5-yl)oxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)oxy)propan-2,3,3,3-d4-2-ol

1-((4-((4-Fluoro-2-methyl-1H-indol-5-yl)oxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)oxy)propan-2,3,3,3-d4-2-ol

  • Catalogue No.:PA STI 088922

  • CAS :

    NA

  • Molecular Formula : C19H15D4FN4O3

  • Molecular Weight : 374.41

Enquire
Details
PA STI 088923

Brivanib alaninate-d4

Brivanib alaninate-d4

  • Catalogue No.:PA STI 088923

  • CAS :

    NA

  • Molecular Formula : C22H20D4FN5O4

  • Molecular Weight : 445.49

Enquire
Details
Tools

Calculators

Normality Dilution Mass molarity
Periodic Table- Pharmaffiliates

Periodic Table

Ask A Scientist-Pharmaffiliates

Ask a Scientist
General Help

General Help